Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 434 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/18
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 10/25/19
End: 03/25/26
Due: 03/25/27
Phase: N/A
Priority: Normal
Start: 03/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 10/22/24
End: 11/04/33
Due: 11/04/34
Phase: N/A
Priority: Normal
Start: 02/21/26
End: 12/30/31
Due: 12/30/32
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 04/12/23
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 12/31/94
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 11/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/22/20
End: 09/22/25
Due: 09/22/26
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 06/30/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/03
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 02/20/23
End: 12/20/27
Due: 12/20/28
Phase: N/A
Priority: Normal
Start: 07/13/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 11/06/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/97
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 05/31/16
Due: 05/31/17
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Phase: N/A
Priority: Normal
Start: 11/14/05
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 04/30/12
End: -
Due: -